Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

about

Detection of Nausea-Like Response in Rats by Monitoring Facial Expression.

P2860

Q37574846-CD9E9DAE-6005-415C-AD0D-7164DAE9DAA6

P2860

Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

Item

http://www.wikidata.org/entity/Q36146524

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

@ast

Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

@en

type

Item

label

Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

@ast

Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

@en

prefLabel

Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

@ast

Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

@en

P1476

Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

@en

P2093

Fumiyasu Okazaki

http://www.w3.org/2001/XMLSchema#string

Hideto To

http://www.w3.org/2001/XMLSchema#string

Hitoshi Sasaki

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Seto

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetr

Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy.

Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.

Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice

Is cisplatin-induced cell death always produced by apoptosis?

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy.

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).

Progressive paresthesias after cessation of therapy with very high-dose cisplatin.

The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.

A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer.

P2888

s12885-016-2777-0

P304

756

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-016-2777-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Keiji Horikawa

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038552308

http://www.w3.org/2001/XMLSchema#string

P698

27678475

http://www.w3.org/2001/XMLSchema#string

P932

5039788

http://www.w3.org/2001/XMLSchema#string

Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

about

P2860

P2860

Influence of dosing times on cisplatin-induced peripheral neuropathy in rats.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932